Direktlänk till inlägg 17 juni 2021
I det här förhöret, se klippet, vittnar MD Pierre Cory om läkemedlet Ivermectins effektivitet vid botande av välkänd infektion.
This is an updated version of Dr. Kory’s testimony on December 8, 2020, including the Q & A part and in better quality (old version: youtube.com/video/CuHq12B_Tvk).
Appearing as a witness Tuesday morning before the Senate Committee on Homeland Security and Governmental Affairs—which held a hearing on "Early Outpatient Treatment: An Essential Part of a C O V I D-19 Solution"— Dr. Pierre Kory, President of the Frontline C O V I D-19 Critical Care Alliance (FLCCC), called for the government to swiftly review the already expansive and still rapidly emerging medical evidence on Ivermectin.
The data shows the ability of the drug Ivermectin to prevent C O V I D-19, to keep those with early symptoms from progressing to the hyper-inflammatory phase of the disease, and even to help critically ill patients recover.
Dr. Kory testified that Ivermectin is effectively a "miracle drug" against C O V I D-19 and called upon the government's medical authorities — the NIH, CDC, and FDA—to urgently review the latest data and then issue guidelines for physicians, nurse-practitioners, and physician assistants to prescribe Ivermectin for C O V I D-19.
Get all relevant information on the FLCCC Alliance's prophylaxis and treatment protocols for COVID-19 on flccc.net
https://vimeo.com/490351508?ref=fb-share&fbclid=IwAR0Bopg4ujhg3tbHJE3Xzd7AkE9lyBEljt5mVVjZ1aloY9hk
mDl2YHWSzHk
Ett års jubileum i 5d-portalen där jag har varit medlem under ett år.En bit in i klippet, cirka 54 minuter, delar jag mina erfarenheter. ...
Håkan Berggren beskriver om bl a programmering:
Från en elbolagskund: SMARTA ELMÄTARE, ETT KRAV FRÅN ENERGIMARKNADSINSPEKTIONEN OCH ETT TVÅNG FÖR ALLMÄNHETEN. Från och med en 1/1 2025, skall alla svenska hushåll vara försedda med de s k ”smarta elmätarna”. Detta är ett direktiv fr...
Må | Ti | On | To | Fr | Lö | Sö | |||
1 | 2 | 3 | 4 | 5 | 6 | ||||
7 | 8 | 9 | 10 | 11 | 12 | 13 | |||
14 | 15 | 16 | 17 | 18 | 19 | 20 | |||
21 | 22 | 23 | 24 | 25 | 26 | 27 | |||
28 | 29 | 30 | |||||||
|